Recent Advances in Spine and Neurosurgery

Recent advances in spine and neurosurgery, from endoscopic and robot-guided spine surgery to fluorescence-guided tumour removal and deep brain stimulation, have made operations smaller, more precise and safer. They have not removed every limit. Major complications after spine surgery run at about 2%, total risk in brain tumour surgery at around 5 to 7%, and patients with complete spinal cord injury are still not expected to recover completely.

Those figures come from Dr. Anil Kumar Kansal, Vice Chairman & HOD - Neuro Surgery & Neuro Spine, BLK-Max Super Speciality Hospital, New Delhi, India, who works across the whole range of neurosurgery, from endoscopic disc surgery and robot-guided spinal screws to colloid cyst removal, deep brain stimulation and microvascular decompression. He is specific about where each technique helps and where it does not, and equally specific about outcomes: the complication rates patients should expect, the recovery they should not expect, and the conditions where the honest answer is that current treatment has limits. This guide maps the field, then sets out those outcome figures and limits, and closes with how referring doctors and specialists can work together across borders.

The selection side of the same field (when neurosurgery is needed, who should not have it and what it costs) is covered in a separate masterclass by Dr. Kansal: recent advances in neurosurgery: when surgery is needed.

Recent advances in spine and neurosurgery: three fronts

The advances fall on three fronts: minimally invasive and robotic spine surgery, endoscopic and image-guided brain surgery, and functional neurosurgery for conditions that medication no longer controls.

Minimally invasive and robotic spine surgery

In the spine, the shift has been from open exposure to endoscopic, percutaneous and small-incision surgery, with Dr. Kansal citing less blood loss, shorter hospital stays, less pain and faster healing as the gains. The range runs from discectomy and kyphoplasty to cervical disc replacement, a paravertebral tumour removed through a 2 cm incision, and robot-guided screw placement. Each technique, with its selection criteria and contraindications, is covered in minimally invasive spine surgery: indications and limits.

Endoscopic and image-guided brain surgery

In cranial surgery, the advance is a layered toolkit: the endoscope for deep lesions, stereotaxy and navigation for localisation, fluorescent dye and intraoperative MRI for complete tumour removal, functional MRI for preserving eloquent brain, and local chemotherapy and radiosurgery for disease surgery cannot control. These are set out in endoscopic brain surgery, from ventriculostomy to colloid cysts.

Functional neurosurgery

For Parkinson's disease, dystonia, drug-resistant epilepsy and trigeminal neuralgia, the advance is surgery that restores function once medication has reached its limit. Timing, device choice and cost are covered in deep brain stimulation for Parkinson's: timing and cost.

Is spine surgery safe? Complication rates

Spine surgery is safe in trained hands: Dr. Kansal puts major complications at about 2% and the risk to life at 0.5%, with 98% of patients doing well. Fear of spine surgery is widespread among patients, and referring doctors are often the ones who have to address it. He gave these figures in the Live Discussion, answering how doctors can counter that fear.

• Major complications overall: about 2%.
• Risk to life: 0.5%.
• Neurological deficit, from injury or infection: 1 to 1.5%.
• Patients who do well: 98%, with 90% doing very well.

His explanation of where complications come from is equally direct. They arise when the operating surgeon is not adequately trained, or where infection rates are high. His own unit performs around 400 to 500 spine operations a year and, in his account, hardly sees an infection in any of them. Indicative costs for spinal decompression and fixation surgery are listed separately.

What recovery to expect after spine surgery

Patients should expect pain relief of 80 to 90%, sometimes 95%, and a spine that is near normal rather than normal. The more common source of dissatisfaction, in Dr. Kansal's experience, is not a complication but an expectation. Some patients believe every pain will disappear and they will become completely normal. That is not achievable, and the reason is timing: patients usually reach surgery at a late stage, after the nerves have been damaged and the bone has deformed.

What surgery can deliver is substantial but bounded:

• Pain relief of 80 to 90%, sometimes 95%. Some pain remains, but the majority goes.
• Benefit varies between patients: some gain 70%, others 80%.
• A spine in which two or three vertebrae have been repaired and fixed is near normal, not normal.
• Muscle weakness, tingling and numbness can persist after surgery.

The surgeon is repairing and correcting, in Dr. Kansal's framing, not creating something new. The outcome that matters is functional: patients who could not walk become able to walk without pain and return to their daily activities.

For referring doctors, the implication is twofold: counselling before referral should set the target at "near normal", and late presentation, with nerve damage and bone deformity already established, limits what surgery can achieve.

How safe is brain tumour surgery?

Total risk in brain tumour surgery is around 5 to 7%, with 93% of patients doing very well, in Dr. Kansal's figures. The fear attached to brain surgery is usually specific: patients worry about losing speech or mental faculties. Dr. Kansal breaks the risk into its components.

• Mortality. Around 1 to 2%, depending on the tumour.
• Neurological deficit. This depends on location. A tumour in the speech area carries a risk of speech difficulty; one in the motor area carries a risk of hand weakness.
• Total risk. Around 5 to 7%, with 93% of patients doing very well.
• With experienced surgeons, the surgical complication rate is now below 5%.

As a general benchmark, operative mortality for elective brain tumour surgery in experienced centres is in the low single digits in percentage terms.

He attributes the reduction in risk to newer methods: localisation under a high-end microscope, neuronavigation and intraoperative dye.

The harder problem is not the operation but the tumour's biology. Benign and less aggressive tumours can be cured by removal. Malignant tumours cannot: even after removal, radiotherapy and chemotherapy, they come back. Dr. Kansal identifies recurrence as the main problem in brain tumour surgery, so the safety of the operation and long-term control of the tumour are separate questions for the patient.

Where current treatment reaches its limits

Can complete spinal cord injury be treated?

Dr. Kansal's position on complete spinal cord injury is unambiguous: these patients are not going to recover completely, and some recover only minimally. Patients with partial injuries do better. Treatment therefore shifts from cure to function and symptom control.

• Rehabilitation for independence. If the hands are working, patients are trained to manage their lives using their hands and a wheelchair.
• Pain and stiffness in the legs. These can be managed with an implanted baclofen pump or morphine pump, a device placed under the skin that delivers the drug directly into the fluid around the spinal cord.
• Dorsal cord stimulation. A dorsal cord stimulator, an implant that delivers mild electrical pulses to the back of the spinal cord, sometimes gives better sensation and reduces spasticity, and combined with physiotherapy some patients regain some power in the legs, enough to help with daily life.

He is careful about the stimulator's limits. Some patients improve with it, but not the majority, and it is not possible to promise that a dorsal cord stimulator will bring complete recovery. What it offers is a chance that symptoms will improve.

Does stem cell therapy work for spinal cord injury?

Not on current evidence. Dr. Kansal ran a stem cell implantation project for spinal cord injury, harvesting cells from the iliac bone and implanting them in the spine. Among around 20 patients, one showed improvement, and that patient may have been recovering on his own with medication. Statistically, the trial found no significant benefit, and it was discontinued. Stem cell therapy for spinal cord injury remains experimental and is not recommended by any major clinical guideline.

This is directly relevant to referring doctors whose patients encounter offers of stem cell treatment for spinal cord injury: the evidence from his own trial does not support it.

What robotic spine surgery cannot yet do

One further limit runs through the session. The spinal robot places screws with high accuracy but cannot yet perform nerve decompression, which is still done by the surgeon under the microscope or endoscope.

How referring doctors can work with the neurosurgeon

Asked how referring doctors can stay involved in their patients' care, Dr. Kansal proposed three practical mechanisms.

Direct consultation, whether or not the patient travels. A referring doctor with a difficult case can discuss it with him as a colleague: share reports, discuss the treatment being planned, and ask whether he would do the same or something different. He offers his number and WhatsApp contact for this purpose, at any time.

A feedback loop after surgery. When a patient returns home, the local doctor takes over day-to-day care. Dr. Kansal wants that doctor to report back on what is being prescribed and what problems arise, so that he can advise on follow-up, such as when to repeat the MRI or CT. Communication, in his view, should be more frequent than it typically is.

Topic-focused clinical exchange. Beyond lectures, he proposes sessions devoted to a single topic, such as brain tumours or the lumbar spine, where participants discuss cases one by one: tumours, fixation, microdiscectomy. The exchange runs both ways. He sees value in passing on what he knows and in learning from referring doctors, who also bring considerable experience of their own.

The model treats surgery as one episode in a longer course of care, and the referring doctor as the person who holds that course together.